Tender detail
Medicinal products containing rituximab as a concentrate for solution for infusion (ATC: L01FA01)
Summary
The contract concerns non-exclusive rebate agreements under Section 130a(8) of the German Social Code, Book V, for finished medicinal products containing rituximab as a concentrate for solution for infusion (ATC: L01FA01). The agreements are offered under an open-house model with uniform contractual terms and an identical access procedure.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.